Source: BioSpace

Neurotech: Neurotech Announces Positive Phase II Results In NT-501 (CNTF) For Macular Telangiectasia

Life Sciences Jobs ...

Read full article »
Neurotech's Competitors | Neurotech's News | Neurotech's Financials
Stay up-to-date with the latest news on Neurotech Pharmaceuticals, Inc.
Est. Annual Revenue
$100K-5.0M
Est. Employees
25-100
Richard Small's photo - CEO of Neurotech Pharmaceuticals, Inc.

CEO

Richard Small

CEO Approval Rating

86/100

Read more
Stay up-to-date with the latest news on Neurotech Pharmaceuticals, Inc.